Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 is a protein that in humans is encoded by the HCN1 gene.

Function

Hyperpolarization-activated cation channels of the HCN gene family, such as HCN1, contribute to spontaneous rhythmic activity in both heart and brain.

Tissue distribution

HCN1 channel expression is found in the sinoatrial node, the neocortex, hippocampus, cerebellar cortex, dorsal root ganglion, trigeminal ganglion and brainstem.

Ligands

  • Ketamine is an inhibitor of HCN1 in addition to its other targets.
  • Propofol also inhibits HCN1.
  • Isoflurane and Sevoflurane inhibit HCN1.

Interactions

HCN1 has been shown to interact with HCN2.

Epilepsy

De novo mutations in HCN1 cause epilepsy.

See also

  • Cyclic nucleotide-gated ion channel

References

Further reading

External links

  • HCN1 protein, human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
  • Overview of all the structural information available in the PDB for UniProt: O60741 (Human Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) at the PDBe-KB.
  • Overview of all the structural information available in the PDB for UniProt: O88704 (Mouse Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1) at the PDBe-KB.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.


Insights into the molecular mechanism for hyperpolarizationdependent

Bipolar switching by HCN voltage sensor underlies hyperpolarization

The HCN domain couples voltage gating and cAMP response in

De novo mutations in HCN1 cause early infantile epileptic

Insights into the molecular mechanism for hyperpolarizationdependent